 ARDSLEY, N.Y.--BUSINESS WIRE--Acorda Therapeutics, Inc. Nasdaq: ACOR today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares of common stock. The reverse stock split became effective at 4:01 p.m. Eastern Time today, and the Companys common stock will begin trading on a split-adjusted basis at the market open on January 4, 2021. The reverse stock split was effected in accordance with the authorization adopted by Aco 